Friday, April 25, 2014
University of Maryland School of Medicine (SOM) Dean E. Albert Reece, M.D., Ph.D., M.B.A., has appointed Terry B. Rogers, Ph.D., as the new Executive Director, Office of Research Affairs (ORA). A distinguished Professor of Biochemistry and former Director of the M.D./Ph.D. Program at the School, Dr. Rogers has extensive experience in research and program management. He currently holds the position of Professor of Biochemistry and Molecular Biology.
“Dr. Rogers’ extensive experience in research and program management makes him an ideal selection for this position,” said Dean Reece, who is also Vice President for Medical Affairs, University of Maryland, and the John Z. and Akiko Bowers Distinguished Professor at the School of Medicine. “I look forward to working collaboratively with Dr. Rogers and the rest of the ORA leadership.”
Dr. Rogers replaces Thomas Hooven, Executive Director of Research Administration, who will be retiring in June 2014. In his new role, Dr. Rogers will be responsible for the activities and resources in the Office of Research Affairs. In that capacity he will coordinate SOM-wide research activities and support faculty efforts in ongoing research programs and in the identification of funding resources for new projects.
Dr. Rogers joined the Faculty at the University of Maryland School of Medicine in the Department of Biochemistry and Molecular Biology where he is currently Professor. In 1996, Dr. Rogers was appointed Director of the School of Medicine’s M.D./Ph.D. Program, which he expanded from a distinct training opportunity with a small group of students, to its current size of nearly 40 students in the program. He was able to secure major National Institutes of Health (NIH) funding for this program to officially establish it as a Medical Science Training Program (MSTP). In addition, Dr. Rogers has held significant leadership positions at the SOM including Course Director for the Medical School “Neuroscience” and the “Biochemistry, and Cellular and Molecular Biology” courses. He has also served on several search committees for Department Chairs and was a member of the SOM Appointments, Promotions and Tenure Committee.
As a researcher, Dr. Rogers’ high-caliber studies have contributed to a broader understanding of the fundamental molecular and electrical properties of cardiac cells. Recently, he has broadened his interests to the role of stem cell biology/signaling in a protective response of heart cells to stress. Over the years, the NIH, the American Heart Association (AHA), the Department of Defense (DOD), the National Science Foundation (NSF) and the Maryland Stem Cell Research Fund have funded his research. Dr. Rogers has also reviewed grants for NIH, NSF, DOD, AHA and the Howard Hughes Medical Institute.
He has held several prominent administrative positions at the UM SOM and nationally. His administrative experience extends to the national level as he was a member of the Steering Committee of the M.D.-Ph.D. Program Section of the GREAT Group of the Association of American Medical Colleges, and the Executive Committee of National Association of M.D.-Ph.D. Programs.
Dr. Rogers has received a myriad of awards including the NIH New Investigator Research Award, the NIH Research Career Development Award, and most recently, the Visiting Distinguished Professor Award from the University of California, Davis School of Medicine in 2011. He is a professional member of the American Society of Biochemistry and Molecular Biology, the Society for Neuroscience, the American Heart Association, the Biophysical Society, and the American Physiological Society.
He received his B.S. in Chemistry from Cornell University, a Ph.D. at the University of California, Davis in Biochemistry followed by postdoctoral training at the University of Nice Medical School, France and a fellowship at the Johns Hopkins Medical School.
“I am honored to have this exceptional opportunity to lead research affairs at the SOM, an organization that is increasingly renowned for its excellence and innovation in research,” said Dr. Rogers. “I look forward to working with our leadership teams to find new ways to support excellence in biomedical basic and clinical research, increase the scope of our scientific discoveries ultimately improving the health of the citizens of Maryland and around the world. In particular, I am excited to focus our resources to bring faculty together in new ways to address critically important problems in health and disease through “Big Science” initiatives.”